CompletedNot Applicable

Time to Accurate Heart Rate on Neonatal Outcomes

United States42 participantsStarted 2021-02-01

Plain-language summary

The goal of this trial is to compare the time to first heart rate displayed for iRes Warmer with ResusView and using iRes Warmer without ResusView when used in the resuscitation (e.g. Cardiopulmonary resuscitation or breathing assistance) of premature newborns (23 to 32+6 weeks gestation).

Who can participate

Age range23 Weeks – 32 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Infants who are delivered to mothers over the age of 16 years of age * Infants delivered at 23+0 to 32+6 weeks estimated gestational age based on the best obstetric estimate at the time of delivery. * Infants without known congenital malformations prior to delivery * Antenatal consent Exclusion Criteria: * Infants who are delivered to mothers under the age of 16 years of age * Known congenital anomalies of newborn prior to delivery * Cardiac defects other than small Ventricular septum defect and Patent ductus arteriosus * Multiples * Declined consent * iRes Warmer with ResusView not available at time of delivery

What they're measuring

Time to Heart Rate Display in iRes Warmer With Resusview

Timeframe: Birth to 10 minutes of life

Trial details

NCT IDNCT04587934

SponsorSharp HealthCare

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-06-30

Results submitted2023-11-20

View on ClinicalTrials.gov More Premature Infant trials